- Advertisement -
Saturday, March 25, 2023
Home Medical Medical Devices Finding an Informed Answer to Your Healthcare Questions

Finding an Informed Answer to Your Healthcare Questions

A human being’s skill-set, as we know, can be many different things, but if we assess the picture in hindsight, none of those iterations will look more valuable than the one that gets to grow on a consistent basis. You see, when an individual is scaling up under each and every situation, they eventually steer themselves towards some really notable milestones along the way. This is proven by everything we have achieved so far, with one big testimony coming from a creation called technology. Technology enjoys a distinctive presence in our lives mainly because of its unprecedented skill-set. Having said that, though, we must also give some credit to the manner in which it used those skills for impacting our entire spectrum. The latter, in particular, will go on to produce various beneficiaries, and our healthcare sector will be a significant part of the said group. In fact, technology’s foray into healthcare couldn’t have arrived at a better time, considering how badly the sector was struggling against an outright obsolete structure. Fortunately, by building upon those ingenious medtech foundations, the sphere will manage to move on, but even after doing so; it will keep improving under one capacity or the other. A recent development does a lot to reinforce the same dynamic.

The researching team at Harvard Wyss Institute has successfully modelled the Environmental Enteric Dysfunction (EED), a childhood inflammatory intestinal disease, on a microfluidic chip, thus conceiving extensive insights into the genetic changes underlying the condition. Dubbed as the first ever in vitro model of the disease, the whole construction is made from two microfluidic channels. While one is lined up with endothelial cells as a proxy for intestinal blood vessels, the other channel sticks to intestinal epithelial cells to mimic the intestine itself. These channels are connected by a nutrient-rich fluid, which flows between the channels, and with the help of a permeable membrane, the nutrients are eventually able to reach the intestinal cells. Interestingly enough, the researchers, to get the most accurate results possible, would source intestinal cell samples from EED patients. After putting them alongside the intestinal channel of the chip, they compared its complete overview to what they picked up from the chips that were lined with healthy cells. According to certain reports, the EED chips showed changes in gene expression across a large number of genes, particularly when certain nutrients were excluded from the nutrient fluid. More importantly, though, they succeeded in mimicking the disease, showing inflammation, intestinal barrier dysfunction, and reduced nutrient absorption, which are all found in human EED patients.

“Functionally, there is something very wrong with these kids’ digestive system and its ability to absorb nutrients and fight infections, which you can’t cure simply by giving them the nutrients that are missing from their diet,” said Amir Bein, a researcher involved in the study. “Our EED model allowed us to decipher what has happened to the intestine, both physically and genetically, that so dramatically affects its normal function in patients with EED.”

Assuming these organ chips prove as sustainable on a larger scale, they can very well pave the way for us to answer many healthcare questions.

Must Read

Data Sciences in the Medical Industry: How powerful is it?

When novel compounds were researched about, to meet the needs of patients who were in critical conditions, medical science had huge growth....

Powering Diverse and Inclusive Clinical Trials

The Food and Drug Administration (FDA) will soon require clinical trial sponsors to submit a plan for improving diversity among clinical trial participants. While...

Improving antibiotic use with novel diagnostic technologies: Challenges Ahead

Antibiotics have revolutionized human medicine in the twentieth century. Deadly diseases such as streptococcal pneumonia or gangrene became curable, and also other advances of...

The power of novel excipients in 505(b)(2) products

The FDA 505(b)(2) regulatory pathway for drug approval, which allows applicants to use existing safety data as evidence, continues to grow in popularity. Innovators...

Related News

Constructing a Convenient Healthcare Experience

Human beings are known for a myriad of different things, but most importantly, they are known for getting better on a consistent basis. This...

Disrupting the Pharmaceutical Space Like Never Before

The human arsenal has a lot more to it than we usually acknowledge, and yet it doesn’t boast a feature more valuable than that...

Weaving a More Informed Healthcare Space

The human arsenal is known for a myriad of different things, but most importantly, it is known for getting better on a consistent basis....

Addressing a Big Old Plague

While the human arsenal has proven itself to be pretty much limitless, it still doesn’t possess anything more valuable than that tendency of ours...

Doubling Down on the Push to Enhance Mental Health

The human arsenal has always been a little on the loaded side, but if we being honest, it is still yet to possess anything...